Starget Pharma: Funding, Investors & Team (Sep 2026)
Starget Pharma is a clinical stage company developing a pipeline of radioligand therapy programs generated using its proprietary Backbone Dynamics peptide platform that leverages backbone cyclic innovations and in-silico AI to rapidly design highly specific Smart Targeted Radioligands (STRs) that deliver focused radiation for the imaging and treatment of hard-to-treat cancers.
Starget Pharma has raised $23.1M across 2 funding rounds on record, the most recent a Series A of $18.0M announced in Feb 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Starget Pharma Company Profile and Key Stats
Latest funding round on record: Feb 2026.
Starget Pharma Funding Rounds
Starget Pharma raised $5.1M in an undisclosed round announced in Oct 2024.
1.3 years later, a Series A of $18.0M was announced in Feb 2026.
Starget Pharma Founders and Leadership Team
No contact details are on record for this team yet.
Starget Pharma Funding Compared to Other Biotechnology Startups
Starget Pharma's latest round of $18.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Starget Pharma in Biotechnology and Ramat Hasharon
Companies Similar to Starget Pharma
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
Starget Pharma Funding FAQs
What does Starget Pharma do?
Starget Pharma is a clinical stage company developing a pipeline of radioligand therapy programs generated using its proprietary Backbone Dynamics peptide platform that leverages backbone cyclic innovations and in-silico AI to rapidly design highly specific Smart Targeted Radioligands (STRs) that deliver focused radiation for the imaging and treatment of hard-to-treat cancers.
How much funding has Starget Pharma raised?
Starget Pharma has raised $23.1M across 2 rounds on record. The most recent is a Series A of $18.0M announced in Feb 2026.
When did Starget Pharma last raise funding?
Starget Pharma's most recent funding round on record is a Series A of $18.0M, announced in Feb 2026.
Who founded Starget Pharma?
FundedIQ lists Sigal Kalmanson Cusnir (Founder) at Starget Pharma.
Where is Starget Pharma headquartered?
Starget Pharma is based in Ramat Hasharon, Tel Aviv, Israel.
How many employees does Starget Pharma have?
Starget Pharma is in the 1-10 employee band.
How does Starget Pharma's funding compare to other Biotechnology startups?
Starget Pharma's latest round of $18.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Starget Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Starget Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.